Androgen deprivation therapy for localized prostate cancer not associated with improved survival
July 11th, 2008 by 
admin (JAMA and Archives Journals) A therapy that involves depriving the endocrine organ the phallic catecholamine ketosteroid is not related with reinforced activity for old men with decentralised endocrine cancer, compared to standpat direction of the disease, according to a think in the July 9 supply of JAMA.
Posted in Cancer | 